HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul J Cote Selected Research
Paul J Cote Research Topics
Disease
18
Infections
01/2013 - 01/2002
6
Chronic Hepatitis B
06/2015 - 06/2002
5
Viremia
10/2008 - 07/2005
2
Persistent Infection
07/2008 - 03/2004
2
Disease Progression
10/2007 - 12/2004
2
Body Weight (Weight, Body)
09/2007 - 07/2005
2
Hepatocellular Carcinoma (Hepatoma)
12/2004 - 04/2004
2
Hepatitis B
11/2004 - 08/2004
1
Thrombocytopenia (Thrombopenia)
06/2015
1
HIV Infections (HIV Infection)
07/2005
1
Chronic Hepatitis (Chronic Active Hepatitis)
12/2004
1
Adenoma (Adenomas)
04/2004
1
Neoplasms (Cancer)
04/2004
1
Hepatitis
08/2002
Drug/Important Bio-Agent (IBA)
8
Antiviral Agents (Antivirals)
IBA
01/2013 - 01/2002
7
Surface Antigens (Surface Antigen)
IBA
10/2009 - 01/2002
6
Vaccines
IBA
05/2011 - 01/2002
6
DNA (Deoxyribonucleic Acid)
IBA
07/2008 - 03/2004
4
clevudine
IBA
10/2005 - 01/2002
3
Pharmaceutical Preparations
IBA
09/2007 - 06/2002
2
Nucleosides
IBA
10/2008 - 11/2004
2
Tenofovir (Viread)
FDA Link
10/2008 - 07/2005
2
adefovir dipivoxil (Hepsera)
FDA Link
10/2008 - 08/2004
2
Lamivudine (Epivir)
FDA Link
10/2008 - 08/2004
2
RNA (Ribonucleic Acid)
IBA
09/2007 - 12/2004
2
Messenger RNA (mRNA)
IBA
04/2003 - 08/2002
2
Cytokines
IBA
04/2003 - 08/2002
1
Toll-Like Receptor 7
IBA
06/2015
1
vesatolimod
IBA
06/2015
1
Enzymes
IBA
06/2015
1
Interferons
IBA
06/2015
1
aluminum sulfate (alum)
IBA
10/2009
1
Racivir
IBA
10/2008
1
Emtricitabine (Emtriva)
FDA Link
10/2008
1
Viral Envelope Proteins
IBA
10/2007
1
formal glycol (dioxolane)
IBA
09/2007
1
Antibodies
IBA
03/2007
1
Antigens
IBA
07/2005
1
Nucleotides
IBA
07/2005
1
Drug Combinations
IBA
12/2004
1
Interleukin-10 (Interleukin 10)
IBA
04/2003
1
Transcription Factors (Transcription Factor)
IBA
04/2003
1
N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)
IBA
02/2002
1
Viral Antigens
IBA
02/2002
1
W 7 (W7)
IBA
02/2002
Therapy/Procedure
8
Therapeutics
06/2015 - 01/2002
3
Oral Administration
10/2008 - 07/2005
2
Immunotherapy
12/2004 - 08/2002
1
Aftercare (After-Treatment)
06/2002